AzTrials
AzTrials

GastroparesisABVN2NCT07881289

ABVN Phase 2 - Vagal Maneuvers

A study testing Vagal Maneuvers in people with Gastroparesis, run by Indiana University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators want to evaluate the effects of noninvasive stimulation of the auricular branch of the vagal nerve (ABVN) on vagal nerve function. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Gastroparesis
What is being tested?
Vagal Maneuvers
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteUnited States
Study dates
24 Nov 2020to 25 Mar 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have a formal diagnosis of gastroparesis or are seeing the GI physician for symptoms related to gastroparesis
  • Aged 18-80 years
  • Willing to perform vagal activity maneuver (Vagal arm)

Who cannot join

  • Have an implanted gastric stimulator
  • Unable to provide consent
  • Pregnant females
  • Prisoners

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Indiana University

    Indianapolis, Indiana, 46202

Other trials in United States

About this study

Official title: Effect of Electrical Stimulation of the Auricular Branch of the Vagus Nerve (ABVN) on Cervical Vagus Nerve Action Potentials Phase 2 - Vagal Maneuvers

The vagus nerve is a nerve that controls many bodily functions, including stomach function. Investigators want to evaluate the effects of noninvasive stimulation of the auricular branch of the vagal nerve (ABVN) on vagal nerve function.

The purpose of the ABVN Phase 2 grant is to expand on previous work evaluating vagally mediated compound nerve action potentials (CNAPs). This will be accomplished through several independent, but related, studies. In this study, investigators will evaluate the effect of vagal stimulation through simple physical techniques (vagal maneuvers) in subjects with gastroparesis.

[This study was originally described in NCT06491758, however a separate record has been created to more accurately reflect the independence of the individual studies supported by the ABVN 2 grant.]

Read the detailed description

Patients with gastroparesis will be recruited for this project, which is expected be completed over approximately 3 hours. If all procedures cannot be completed in a single visit, participants may return on a second day to complete them.

When participants arrive, electrodes are placed over the right and left vagus nerve (to record vagal nerve activity), chest (to record electrocardiogram, or ECG) and stomach area (to record electrogastogram, or EGG). A 10 minute baseline recording of vagal nerve activity, electrocardiogram (ECG) and electrogastrogram (EGG) is then completed prior to beginning the vagal maneuvers.

Participants may be asked to perform any of the following maneuvers:

  • Cough: Each subject will be asked to generate approximately 6 to 8 forceful and sustained coughs over 5 to 10 seconds.
  • Cold stimulus to face: An ice pack or a washcloth soaked in ice water will be placed on each subject's face for about 10 seconds to mimic the physiological response of being submerged in cold water (Diver's Reflex)
  • Carotid Massage: This technique is performed with the subject's neck in an extended position with the head turned away from the side being massaged. Only one side is massaged at a time. Pressure is applied underneath the angle of the jaw in a gentle circular motion for about 10 seconds. The subject is monitored throughout.
  • Gagging: A tongue depressor is briefly inserted into the subject's mouth touching the back of the throat, which causes the person to reflexively gag.
  • Valsalva maneuver: The subject is instructed to bear down as if they were having a bowel movement. The subject is asked to blow through a mouthpiece that is hooked to a device used in clinical spirometry until the pressure reaches 10mmHg.Alternatively, we can have the subject blow through the barrel of a 10 ml syringe for 15-20 seconds. This maneuver increases intrathoracic pressure and stimulates the vagus nerve.

After performing a maneuver for 10 seconds, another 8 minutes of recording will be made before doing any additional maneuvers.

Participants may also be asked to perform one or more eating maneuvers after an overnight fast.

  • Eating: After 20 minutes of baseline recordings, subjects will be asked to drink 8 ounces of either water or Ensure Original. After the fluid is consumed, an additional 20 minutes of recordings will be made.

Maneuvers will be selected at the investigator's discretion and not all maneuvers will be completed. If both the water and Ensure eating maneuvers are selected, they will be completed at two separate visits.

Conditions
Gastroparesis
Being tested
Vagal Maneuvers
Medical subject headings
Gastroparesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vagal ManeuversOther

    Subjects will be asked to perform various maneuvers to stimulate the vagus nerve:

    • Cough: Produce 6 to 8 forceful coughs over 5 to 10 seconds
    • Cold stimulus to face: Have an ice cold washcloth placed on their face for 10 seconds.
    • Carotid massage: While the neck is extended and the head turned away from the side being massaged, pressure is applied underneath the angle of the jaw in a gentle circular motion for about 10 seconds.
    • Gagging: a tongue depressor is briefly inserted into the mouth touching the back of the throat.
    • Valsalva maneuver: subjects will will be asked to bear down as if they were having a bowel movement. They will be asked to blow through a mouthpiece that is hooked to a machine that measures how hard they are blowing. Alternatively, they can blow through the barrel of a 10 ml syringe for 15-20 seconds.
    • Eating: Subjects will be asked to drink 8 ounces of water and/or Ensure Original after fasting overnight
Study groups in NCT07881289
Study groupRoleWhat they receive
Gastroparesis SubjectsExperimentalSubjects with a confirmed diagnosis of gastroparesis.
Receives: Other: Vagal Maneuvers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Amplitude of vagal nerve compound action

    To measure the amplitude of vagal nerve compound action potentials during vagal maneuvers.

    Measured: 3 hours

  2. Respiratory Changes in heart rate during stimulation

    To measure respiratory changes in heart rate during vagal maneuvers.

    Measured: 3 hours

  3. Changes in amplitude of the surface electrogastrogram

    To measure the changes of surface electrogastogram during vagal maneuvers.

    Measured: 3 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Oct 2026
  2. Study start24 Nov 2020
  3. Primary completion25 Mar 2022
  4. Study completion25 Mar 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07881289
Sponsor's protocol ID
2006075899-C
Other IDs
1OT2OD028183-01
Acronym
ABVN2
Status last verified
Aug 2026
First submitted
12 Oct 2026
Last updated
19 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified data may be shared with other researchers for similar purposes as to this study

Questions about this trial

What is this clinical trial studying?

A study testing Vagal Maneuvers in people with Gastroparesis, run by Indiana University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Amplitude of vagal nerve compound action (time frame: 3 hours). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2026; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in